CSL Behring Announces First Two Patients Treated With HEMGENIX® (etranacogene Dezaparvovec) Gene Therapy For Hemophilia B In Europe
MARBURG, Germany, July 4 (Bernama-GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated…